Fatty liver disease (MASLD/MASH) trials in Russia
1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleGepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly
- Where
- Tyumen
- Age
- 18 years to 65 years
- People
- 90
- Run by
- Phenomen Pharma
See details and how to joinNCT07068191